Abstract
Aim: To describe the clinical, imaging, and histopathological features of fibrous hamartoma of infancy (FHI) in the eyelid, a rare differential diagnosis for eyelid lesions. Methods: We describe the case of a 7-month-old patient with a FHI in the eyelid that was diagnosed after surgical removal. The unique histopathological appearance of the triphasic histologic components provided the diagnosis. Conclusions: FHI is included in the long list of differential diagnosis for eyelid lesions in infancy. Therefore, it is important for the ophthalmologists to be familiar with this entity in order to avoid misdiagnosis of other fibromatosis and malignant tumor as well as unnecessary aggressive treatment.
Introduction
Fibrous hamartoma of infancy (FHI) is a rare, benign, fibroproliferative lesion that develops during the first 2 years of life, and up to 25% of cases are discovered at birth [1,2]. It presents as a solitary, asymptomatic mass-like lesion located in the subcutaneous layer or the reticular dermis, and it is poorly demarcated from the adjacent soft tissue [3]. The clinical and radiologic features of this lesion are nonspecific and can mimic other soft tissue lesions. Since the initial description of FHI in 1956 by Reye [4], the diagnosis is made by histological examination. This tumor has been recognized by its classic triphasic histologic components of mature fibroblastic/myofibroblastic tissue, immature mesenchymal tissue, and mature adipose tissue [4]. The lesion may be progressive with varying paces (from slow to rapid), and the preferred treatment is surgical excision [5]. However, complete resection is often neither feasible nor needed because of cosmetic and/or functional implications. Although local recurrence may occur after incomplete excision [1], the prognosis remains excellent [6].
The usual anatomic locations of FHI include the upper extremities, axilla, and upper back [5]. Although it has been mentioned few times in the differential diagnosis for eyelid lesions in infancy [7,8,9], to the best of our knowledge, there are only two earlier case reports of FHI in the eyelid [6,10]. Here, we present the clinical, imaging, and histopathological features of FHI to make ophthalmologists more familiar with this rare entity.
Case Report
A 7-month-old, healthy, female baby was examined by the pediatric ophthalmologist due to a left upper eyelid lesion that appeared at birth and had been growing since then. In order to prevent amblyopia, closure of the right eye for a few hours per day was recommended, and she was referred to the oculoplastic clinic at our institution for consultation and treatment.
On examination, the left upper eyelid lesion was solid and mobile with rubber consistency (fig. 1a). A mechanical ptosis was observed. The rest of the ophthalmic examination was normal. Magnetic resonance imaging of the orbits demonstrated a well-marginated, ovoid, osteolytic mass in the superior left bony orbit. The mass was isointense relative to the brain parenchyma on T1-weighted images and hyperintense to the brain parenchyma on T2-weighted images. After administration of gadolinium contrast, the mass demonstrated marked homogeneous enhancement (fig. 2). The differential diagnosis after imaging and clinical evaluation included the following etiologies: Langerhans cell histiocytosis, fibrous dysplasia, juvenile ossifying fibroma, infantile fibrosarcoma, neuroblastoma, and primitive neuroectodermal tumor. Excision of the lesion was recommended.
During surgery, a solid, infiltrative lesion, harder than normal tissue, with no obvious borders was identified (fig. 1b) and excised. Since the lesion was infiltrative, with no clear borders, frozen sections were performed. Fibrous tissue with bland spindle cells was histologically recognized, and the surgical margins were found to be free of lesion.
After fixation and embedding in paraffin, the hematoxylin and eosin-stained sections disclosed an ‘organoid' growth pattern of fascicles of mature fibroblastic tissue, with collagen deposition, hypercellular islands of round to spindle cells set within slightly myxoid stroma, and mature adipose tissue (fig. 3a-c).
The spindle cells in the hypercellular islands had bland nuclei and showed no mitotic activity. On immunostains, CD34 stained positively both for the fibroblastic fascicles and the hypercellular areas, Bcl-2 was positive only in the hypercellular areas, and the stains for β-catenin, S100, CD68, and MNF116 were negative. Based on the morphological features and the results of the immunohistochemical stains, the diagnosis of FHI was made.
Today, the patient is still in follow-up in the oculoplastic clinic. The mechanical ptosis is less prominent, but there is still swelling in the nasal part of the eyelid, probably from remnants of the lesion for which future surgery is planned (fig. 1c).
Discussion
In this case report, the clinical, imaging, and histopathological features of FHI located in the eyelid are described. FHI is a rare tumor and location in the eyelid is unusual.
The clinical and radiologic features of FHI are similar to other tumors. Therefore, the definite diagnosis is made only by histopathological examination. The histopathological appearance of the triphasic histologic components of mature fibroblastic tissue, immature mesenchymal tissue, and mature adipose tissue [5] is unique to this tumor, which led to the diagnosis in our case.
FHI is included in the long list of differential diagnosis for eyelid lesions in infancy [8]. This differential diagnosis includes a variety of reactive lesions and benign and malignant neoplasms: juvenile hyaline fibromatosis, lymphoma, neuroblastoma, infantile myofibroma, leiomyoma, fibrous dysplasia, nonossifying fibroma, dermoid cyst, and more. Therefore, it is important for the ophthalmologists and the pathologists to be familiar with this entity in order to avoid misdiagnosis of other fibromatosis and malignant tumor that may result in unnecessary aggressive treatment.
Statement of Ethics
The patient's parents agreed to the publication of the clinical photographs.
Disclosure Statement
The authors have no potential conflicts of interest to disclose.